Catalyst Wire Dossier Catalyst Wire Dossier

3VM1001 Cream

· CDA Research Group, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 3VM1001 Cream, covering 2015-08-21 to 2018-07-10. Get the full timeline:

Most recent: Clinical Trial Update: 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) [EARLY_Phase 1]

See pricing